BHC · BAUSCH HEALTH COS INC

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, Czech Republic, Slovakia, Ukraine, Bulgaria, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

2150 St. Elzéar Blvd. West, Laval, QC, H7L 4A8, Canada
Drug Manufacturers - Specialty & Generic
Healthcare

Market Cap

2.169B

52 Wk Range

$4.33 - $8.00

Previous Close

$5.73

Open

$5.73

Volume

3,281,333

Day Range

$5.60 - $5.86

Enterprise Value

21.09B

Cash

1.825B

Avg Qtr Burn

N/A

Insider Ownership

11.12%

Institutional Own.

65.00%

Qtr Updated

Jun 30th 2026